Patent Number: 8,298,801

Title: Methods and compositions for the treatment of cancer

Abstract: The present invention is directed toward the delivery of toxic agents to pathogenic cells, particularly cancer cells. In some embodiments, the toxic agent is a human ribonuclease or similar agent that is toxic to cells.

Inventors: Kink; John A. (Madison, WI), Strong; Laura E. (Stoughton, WI), Shahan; Mark N. (Madison, WI)

Assignee: Quintessence Biosciences, Inc.

International Classification: C12N 9/22 (20060101); A61K 38/46 (20060101); C12N 9/00 (20060101); C12N 9/16 (20060101); A61K 38/47 (20060101); C12N 9/14 (20060101)

Expiration Date: 2020-10-30 0:00:00